Abstract:Fibrillogenesis of amyloid beta-protein (A beta) has been thought to be implicated in the progression of Alzheimer's disease (AD). Therefore, development of high-efficiency inhibitors is one of the strategies for the prevention and treatment of AD. Serum albumin has been found to capture A beta monomers through its hydrophobic groove and suppress amyloid formation, but the inhibition efficiency is limited. Inspired by the strong inhibition potency of a basic protein, human lysozyme, we have herein proposed to develop a basified serum albumin by converting carboxyl groups into amino groups with ethylenediamine conjugated on the protein surface. The idea was verified with both bovine and human serum albumins (BSA/HSA). Four basified BSA (BSA-B) preparations with amino modification degrees (MDs) from 8.0 to 41.5 were first synthesized. Extensive biophysical and biological analyses revealed that the inhibition potency significantly increased with increasing amino MD. BSA-B of the highest MD (41.5), BSA-B4, which had an isoelectric point of 9.7, presented strong inhibition on A beta(42) fibrillation at a concentration as low as 0.5 mu M, at which it functioned similarly with 25 mu M native BSA to impede 25 mu M A beta fibrillation. Cell viability assays also confirmed that the detoxification of 5 mu M BSA-B4 was superior over 25 mu M native BSA by increasing cell viability from 60.6% to 96.0%. Fluorescence quenching study unveiled the decrease of the binding affinity between A beta(42) and the hydrophobic pocket region of BSA-B4, while quartz crystal microbalance experiments demonstrated that the binding constant of BSA-B4 to A beta(42) increased nearly 5 times. Therefore, the increase of electrostatic interactions between BSA-B4 and A beta(42) was the main reason for its high potency. Hence, aminated BSA achieved a conversion of binding way to A beta from a mainly single-site hydrophobic binding to multiregional electrostatic interactions. Similar results were obtained with basified HSA preparations on inhibiting the amyloid formation and cytotoxicity. This work has thus provided new insights into the development of more efficient protein-based inhibitors against A beta fibrillogenesis.

Serum Albumin Prevents Protein Aggregation and Amyloid Formation and Retains Chaperone-like Activity in the Presence of Physiological Ligands

Chaperone-like features of bovine serum albumin: a comparison with α-crystallin

Insight into the Inhibition Effect of Acidulated Serum Albumin on Amyloid Β-Protein Fibrillogenesis and Cytotoxicity.

Bovine serum albumin prevents human hemoglobin aggregation and retains its chaperone-like activity

αs-casein inhibits the pressure-induced aggregation of β-lactoglobulin through its molecular chaperone-like properties

Amyloid Capture and Aggregation Inhibition by Human Serum Albumin

Modification of Serum Albumin by High Conversion of Carboxyl to Amino Groups Creates a Potent Inhibitor of Amyloid β-Protein Fibrillogenesis.

Multipronged Regulatory Functions of Serum Albumin in Early Stages of Amyloid-β Aggregation

Inhibition of toxic metal-alpha synuclein interactions by human serum albumin

αB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid β-peptide and β2-microglobulin

Multifunctionality of Acidulated Serum Albumin on Inhibiting Zn2+-Mediated Amyloid Β-Protein Fibrillogenesis and Cytotoxicity

Understanding how natural sequence variation in serum albumin proteins affects conformational stability and protein adsorption

Serum Albumin in Health and Disease: Esterase, Antioxidant, Transporting and Signaling Properties

Modulation Effect of Acidulated Human Serum Albumin on Cu2+-mediated Amyloid Β-Protein Aggregation and Cytotoxicity under a Mildly Acidic Condition.

Inhibiting amyloid-like aggregation through bio-conjugation of proteins with polymer surfactant

Fibrinogen has chaperone-like activity.

Molecular Chaperone-like Properties of an Unfolded Protein, αs-Casein

Chaperone-like Activity of Β-Casein

The unhappy chaperone

Structural changes in α-synuclein affect its chaperone-like activity in vitro

Albumin, an interesting and functionally diverse protein, varies from 'native' to 'effective' (Review)